Two novel and correlated CF-causing insertions in the (TG)mTn tract of the CFTR gene.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 12 07 2019
accepted: 06 08 2019
entrez: 9 10 2019
pubmed: 9 10 2019
medline: 12 3 2020
Statut: epublish

Résumé

Two novel and related pathogenic variants of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene were structurally and functionally characterized. These alterations have not been previously described in literature. Two patients with diagnosis of Cystic Fibrosis (CF) based on the presence of one mutated allele, p.Phe508del, pathological sweat test and clinical symptoms were studied. To complete the genotypes of both patients, an extensive genetic and functional analysis of the CFTR gene was performed. Extensive genetic characterization confirmed the presence of p.Phe508del pathogenic variant and revealed, in both patients, the presence of an insertion of part of intron 10 in intron 9 of the CFTR gene, within the (TG)m repeat, with a variable poly-T stretch. The molecular lesions resulted to be very similar in both patients, with only a difference in the number of T in the poly-T stretch. The functional characterization at RNA level revealed a complete anomalous splicing, without exon 10, from the allele with the insertion of both patients. Consequently, the alleles with the insertions are expected not to contribute to the formation of a functional CFTR protein. Molecular and functional features of these alterations are compatible with the definition of novel CF-causing variants of the CFTR gene. This also allowed the completion of the genetic characterization of both patients.

Identifiants

pubmed: 31593572
doi: 10.1371/journal.pone.0222838
pii: PONE-D-19-19571
pmc: PMC6782095
doi:

Substances chimiques

CFTR protein, human 0
Cystic Fibrosis Transmembrane Conductance Regulator 126880-72-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0222838

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Hum Mutat. 2004 Apr;23(4):343-57
pubmed: 15024729
J Cyst Fibros. 2015 Nov;14(6):687-99
pubmed: 26526359
Semin Respir Crit Care Med. 2015 Apr;36(2):180-93
pubmed: 25826586
BMC Med Genomics. 2018 Feb 13;11(Suppl 1):13
pubmed: 29504914
Genet Med. 2010 Sep;12(9):548-55
pubmed: 20706124
Gene Ther. 2010 Nov;17(11):1341-54
pubmed: 20535216
Lancet. 2016 Nov 19;388(10059):2519-2531
pubmed: 27140670
Anal Biochem. 1979 Nov 1;99(2):316-20
pubmed: 574722
Gene. 2017 Aug 30;626:282-289
pubmed: 28456595
Nat Genet. 2013 Oct;45(10):1160-7
pubmed: 23974870
Anal Biochem. 2006 Jun 15;353(2):226-35
pubmed: 16635477
Mol Med. 2015 Apr 21;21:257-75
pubmed: 25910067
J Med Genet. 2017 Apr;54(4):224-235
pubmed: 27738188
Mol Biol Cell. 2016 Feb 1;27(3):424-33
pubmed: 26823392
J Cyst Fibros. 2015 Nov;14(6):706-13
pubmed: 25630966
Clin Chem Lab Med. 2011 Sep;49(9):1447-51
pubmed: 21627495
Nat Rev Genet. 2015 Jan;16(1):45-56
pubmed: 25404111
Clin Chem Lab Med. 2018 Jun 27;56(7):1046-1053
pubmed: 29427548
Clin Transl Sci. 2015 Oct;8(5):606-10
pubmed: 26073768
Ann Am Thorac Soc. 2017 Nov 15;15(2):209-216
pubmed: 29140739
Fertil Steril. 2004 Nov;82(5):1316-22
pubmed: 15533353
J Mol Diagn. 2017 Sep;19(5):788-800
pubmed: 28736296
J Cyst Fibros. 2005 Aug;4 Suppl 2:7-13
pubmed: 15996905
J Cyst Fibros. 2019 May;18(3):420-424
pubmed: 30879989
Eur J Pediatr. 1997 Oct;156(10):770-2
pubmed: 9365065
Hum Reprod Update. 2012 Nov-Dec;18(6):703-13
pubmed: 22709980
Pediatrics. 1959 Mar;23(3):545-9
pubmed: 13633369
Nat Genet. 1993 Feb;3(2):151-6
pubmed: 7684646
J Mol Diagn. 2016 Jul;18(4):554-65
pubmed: 27157324
Pediatr Pulmonol. 2016 Oct;51(S44):S45-S48
pubmed: 27662103
BMC Pulm Med. 2015 Dec 01;15:151
pubmed: 26627849
Transl Res. 2016 Feb;168:40-49
pubmed: 25940043
J Cyst Fibros. 2015 Jul;14(4):447-52
pubmed: 25583415
J Pediatr. 2017 Feb;181S:S4-S15.e1
pubmed: 28129811
J Cyst Fibros. 2011 Jun;10 Suppl 2:S86-102
pubmed: 21658649

Auteurs

Silvia Pierandrei (S)

Dept. of Mother-Child and Urologic Sciences, Sapienza University of Rome, Rome, Italy.

Giovanna Blaconà (G)

Dept. of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

Benedetta Fabrizzi (B)

Cystic Fibrosis Care Center, Mother - Child Department, United Hospitals, Ancona, Italy.

Giuseppe Cimino (G)

Cystic Fibrosis Care Center, Umberto I Hospital, Rome, Italy.

Natalia Cirilli (N)

Cystic Fibrosis Care Center, Mother - Child Department, United Hospitals, Ancona, Italy.

Nicole Caporelli (N)

Cystic Fibrosis Care Center, Mother - Child Department, United Hospitals, Ancona, Italy.

Antonio Angeloni (A)

Dept. of Experimental Medicine, Sapienza University of Rome, Rome, Italy.

Marco Cipolli (M)

Cystic Fibrosis Care Center, Mother - Child Department, United Hospitals, Ancona, Italy.

Marco Lucarelli (M)

Dept. of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Pasteur Institute Cenci Bolognetti Foundation, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH